<DOC>
	<DOCNO>NCT01846533</DOCNO>
	<brief_summary>Some possible humoural cellular mechanism diabetes related osteoporosis/fractures propose summarzied follow , ( 1 ) Diabetes mellitus increase osteoclast function decrease osteoblast function , thereby lead accelerate bone loss , osteopenia osteoporosis . ( 2 ) DM/hyperglycemia induces production macrophage colony stimulate factor ( MCSF ) , tumor necrosis factor ( TNF ) -α receptor activator nuclear factor-κB ligand ( RANKL ) , osteoblast-derived activator osteoclast proliferation differentiation . ( 3 ) DM/hyperglycemia suppresses osteoblast proliferation function , part , decrease runtrelated transcription factor ( Runx ) -2 , osteocalcin osteopontin expression . ( 4 ) Adipogenic differentiation mesenchymal stem cell increase indicated overexpression adipocyte differentiation marker , include peroxisome proliferator-activated receptor ( PPAR ) -g , adipocyte fatty acid bind protein ( aP2 ) , adipsin resistin . A decrease neovascularization may aggravate bone loss . ( 5 ) Bone quality also reduce result advance glycation end product ( AGE ) production , may eventually result low impact fragility fracture . DM associated osteoporosis/fracture . The underlie mechanism , especially type 2 DM , mandate DM-osteoporosis cohort elucidate . In clinical practice , develop preventive strategy osteoporotic-fracture also necessary .</brief_summary>
	<brief_title>Osteoprosis Type 2 Diabetic Patients- Cohort Study</brief_title>
	<detailed_description>It become apparent type 1 type 2 diabetes mellitus associate increase risk osteoporosis-associated fracture . A meta-analysis Vestergaard show patient type 1 DM decrease bone mineral density increase fracture risk . This study note 6.9 relative risk hip fracture , expect relative risk fracture 1.4 base BMD . This finding suggests increase fracture risk entirely account low BMD . It demonstrate presence diabetic microvascular complication , include ophthalmic , nephropathic , neurological , lead high risk hip fracture patient type 1 DM . Unlike patient type 1 DM , patient type 2 DM average high BMD age-matched control . However , several study demonstrate patient type 2 DM high risk hip , proximal humerus , foot fracture . Data Women 's Health Initiative Observational Study indicate post-menopausal woman diabetes increase risk hip , foot , spine fracture , fracture overall . For give BMD , diabetic bone appear less strong therefore likely fracture . Insulin-like growth factor ( IGF ) -1 , insulin , bone morphogenetic protein osteoprotegerin ( OPG ) , serve anabolic signal promote bone formation . Among anabolic mediator , liver-derived IGF-1 particular interest since profound growth retardation , small bone size , low BMD osteoporosis report IGF-1 IGF-1 receptor deficiency . Furthermore , insulin find directly induce osteogenic action increase cell proliferation , differentiation , alkaline phosphatase activity expression type Ⅰcollagen osteocalcin human osteoblast-like MG-63 cell . Type 1 DM feature low circulate insulin IGF-1 level usually occur young child prior peak bone mass attainment , whereas type 2 DM common adult already attain peak bone mass .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>1. inclusion:4099 year old type 2 DM patient 2. exclusion : organization people</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>